Aspire Biopharma Holdings Inc (NASDAQ:ASBP) price closed lower on Tuesday, May 20, and dropping -3.86% below its previous close.
A look at the daily price movement shows that the last close reads $0.25, with intraday deals fluctuated between $0.2212 and $0.2556. The company’s 5Y monthly beta was ticking 0.908. Taking into account the 52-week price action we note that the stock hit a 52-week high of $15.80 and 52-week low of $0.22. The stock subtracted -51.45% on its value in the past month.
Aspire Biopharma Holdings Inc, which has a market valuation of $11.90 million, is expected to release its quarterly earnings report in June.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give ASBP a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that ASBP’s price is at present -33.07% off the SMA20 and -51.71% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 26.26, with weekly volatility standing at 25.30%. The indicator jumps to 16.90% when calculated based on the past 30 days. Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s beta value is holding at 0.60, while the average true range (ATR) indicator is currently reading 0.08.
An analysis of the Aspire Biopharma Holdings Inc (NASDAQ:ASBP) stock in terms of its daily trading volume indicates that the 3-month average is 687.15K. However, this figure increases on the past 10-day timeline to an average of 1.27 million.
Current records show that the company has 48.90M in outstanding shares. The insiders’ percentage holdings are 24.04% of outstanding shares while the percentage share held by institutions stands at 2.90%. The stats also highlight that short interest as of 2025-04-30, stood at 98369.0 shares, which puts the short ratio at the time at 0.51. From this we can glean that short interest is 28.00 of company’s current outstanding shares. Notably, we see that shares short in April rose slightly given the previous month’s figure stood at 13088.0. But the -97.91% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
